New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests:
Brought to you by 
Ventana teams with Bayer on companion diagnostic for antibody-drug conjugate
Jan 2012
Executive Summary
In its fourth collaboration so far this month, and its second with a Big Pharma, Ventana Medical Systems Inc. (slide staining, automated tissue processing, and other anatomical pathology tools; part of Roche Diagnostics Corp.) is creating a companion diagnostic for one of Bayer HealthCare Pharmaceuticals AG’s anti-cancer antibody-drug conjugates.
Deal Industry
-
Biotechnology
-
Large Molecule
- Antibodies
- Pharmacogenetics-Pharmacogenomics
-
Large Molecule
-
In Vitro Diagnostics
- Chemistry, Immunoassay
- Molecular Diagnostics & Genetic Testing
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- R+D and Marketing-Licensing
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Ventana teams with Bayer on companion diagnostic for antibody-drug conjugate
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice